Immune heparin-induced thrombocytopenia (HIT) is a relevant adverse drug reaction
consisting in a hypercoagulable state caused by an anticoagulant agent. The incidence is …

Heparin-induced thrombocytopenia (HIT) is an immunoglobulin-mediated adverse drug
reaction associated with a high risk of thrombotic complications. The pathogenic antibody …

Heparin-induced thrombocytopenia (HIT) is a drug-mediated, prothrombotic disorder caused
by immunization against platelet factor 4 (PF4) after complex formation with heparin or other …

Heparin-induced thrombocytopenia (HIT) is an immune-mediated disorder caused by the
development of antibodies to platelet factor 4 (PF4) and heparin. The thrombocytopenia is …

Heparin-induced thrombocytopenia (HIT) is an immune reaction in response to platelet
factor 4-heparin complexes, which results in increased platelet activation and …

Heparin-induced thrombocytopenia (HIT) is an immune response to heparin that can
progress to severe thrombosis, amputation, and in some cases death. The diagnosis and …

Heparin-induced thrombocytopenia (HIT) is an immune-mediated adverse drug effect that is
characterized by platelet activation, hypercoagulability, and a resulting increased risk for …

Heparin‐induced thrombocytopenia (HIT) is a relatively common prothrombotic adverse
effect of heparin both unfractionated and (less often) low‐molecular‐weight heparin caused …

BACKGROUND AND OBJECTIVE: There are two types of heparin-induced
thrombocytopenia (HIT). HIT I is characterized by a transitory, slight and asymptomatic …

Heparin-induced thrombocytopenia (HIT) is a serious adverse effect of heparin exposure
that can progress to severe thrombosis, amputation, or death. HIT is an immune response in …